ArticleJournal of Ayurveda and integrative medicine
Comparative study of Anuvasana Basti with constant and escalating dose as an alternative to Snehapana in Purvakarma of Vamana and Virechana.
Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Microbiome in Health and Disease from the Perspective of Modern Medicine and Ayurveda.Medicina (Kaunas, Lithuania) · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSnehapana is the essential step prior to Vamana and Virechana (therapeutic vomiting and purgation). But it was found that 10-15% patients are reluctant towards Snehapana hence may deprive the benefits of Shodhana. These inconveniences made us think about effective alternative to counter drawbacks of Snehapana. On the basis of literature review and pilot study, it was confirmed that, Anuvasana Basti can be administered as an alternative for Snehapana.
objectiveTo evaluate samyak snigdha lakshana achieved by administration of Anuvasana Basti and to evaluate outcomes of Vamana and Virechana. MATERIALS AND
methodsSpecially designed basti pouches were used according to doses. In group A, constant dose of processed sesame oil (120 ml) and rock salt (500 mg) was used. In group B, the dose was escalating started with 120 ml and 500 mg with 25 ml and 100 mg increase in sesame oil and rock salt respectively for maximum seven days.
resultsPatients from group B showed better results than group A i.e. 29 patients showed symptoms of proper oleation. Mridu koshtha required minimum dose and duration for getting proper symptoms of oleation. Outcome of Vamana and Virechana were also very promising.
conclusionsHence it can be concluded that Anuvasana Basti in escalating dose can be used as an alternative for Snehapana.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.